الفهرس 
INTRODUCTION AND AIM OF THE WORKOnly 14 pages are availabe for public view
 |  | from | 187 |  |  |
| | | from | 187 | | |
Abstract
The aim of this study is to evaluate the safety and efficacy of different pharmaco therapeutic agents in the treatment of symptomatic BPH as measured by reduction of symptoms and increase in the peak flow rate.
Conclusion:
The matter of how best to treat BPH patients remains the subject of considerable debate however; medical treatment of BPH is a hopeful option to minimize patients suffering from the symptomatic disease. The main pharmacological options for the treatment of BPH being those Alpha adrenergic receptors blockers, 5 Alpha reductase inhibitors and phytotherapy the evolution of these options may be the starting point in this context.